Ethacrynic Acid
Composition
This formulation contain Ethacrynic Acid as active agent
Indications
the treatment of edema associated with conditions such as congestive heart failure, renal disease, and hepatic cirrhosis
Side effects
dehydration, dizziness, muscle cramps, and increased urination
Precautions
aution is advised in patients with a history of sulfonamide or sulfonylurea allergy, renal impairment, or hepatic dysfunction
Contraindications
Contraindications include anuria , hypersensitivity to ethacrynic acid or sulfonamide-derived Formulations, and electrolyte depletion.
Dosage and administration
directed by a healthcare professional
Countries
Available Forms
Tablet, Injection
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai